...
首页> 外文期刊>Infection >Chlamydia pneumoniae Infection and Restenosis in Patients with Coronary Heart Disease.
【24h】

Chlamydia pneumoniae Infection and Restenosis in Patients with Coronary Heart Disease.

机译:冠心病患者的肺炎衣原体感染和再狭窄。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The aim of this study was to establish whether Chlamydia pneumoniae is implicated in the development of restenosis in patients with coronary heart disease (CHD) after percutaneous transluminal coronary angioplasty (PTCA). PATIENTS AND METHODS: 67 patients were selected for study after they underwent control angiography after PTCA. Sera were tested for anti-chlamydial antibodies with a genusspecific ELISA and a species-specific microimmunofluorescence test (MIFT). Oropharyngeal specimens were examined for the presence of antigen with a Chlamydia immunofluorescence test (IFT), C. pneumoniae IFT and semi-nested PCR. In addition, anamnestic findings were also included. To determine the general level of antibodies, an age- and sexmatched control group of 180 persons was also examined for Chlamydia and C. pneumoniae serology. RESULTS: Coronary angiography revealed that 31 of the 67 patients had developed a restenosis. There was no significant correlation between serological and angiographic findings. However, the MIFT showed a higher positive rate, especially in IgA, in the restenosis group. C. pneumoniae was detected in the oropharynx by PCR and/or IFT in 20.8% and 16.0% of the cases in patients with and without a restenosis. PCR found more C. pneumoniae-positive cases in the restenosis patients than IFT. No association was found between the detection of Chlamydia antigen and serology. The women with restenosis were more frequently smokers (p = 0.012). Men with restenosis were significantly older (p = 0.015). C. pneumoniae serology based on the rELISA or the MIFT did not show any correlation with restenosis. CONCLUSION: No evidence was found to suggest that positive C. pneumoniae serology is a risk factor for the development of restenosis. However, whether the species-specific serological test, especially for IgA-antibodies, and the detection of C. pneumoniae in oropharyngeal specimens by PCR might be reliable diagnostic markers in these cases remains to be determined.
机译:背景:本研究的目的是确定经皮腔内冠状动脉成形术(PTCA)后,冠心病(CHD)患者的肺炎衣原体是否与再狭窄的发生有关。患者与方法:选择了67例PTCA后进行了对照血管造影的患者进行研究。使用属特异性ELISA和物种特异性微免疫荧光测试(MIFT)对血清进行抗衣原体抗体测试。用衣原体免疫荧光试验(IFT),肺炎衣原体IFT和半巢式PCR检测口咽标本中抗原的存在。此外,还包括记忆检查结果。为了确定抗体的总体水平,还对年龄和性别相匹配的180人对照组进行了衣原体和肺炎衣原体血清学检查。结果:冠状动脉造影显示67例患者中有31例发生了再狭窄。血清学检查和血管造影检查结果之间无显着相关性。但是,再狭窄组的MIFT阳性率更高,尤其是在IgA中。通过PCR和/或IFT在有再狭窄和没有再狭窄的患者中通过PCR和/或IFT在口咽中检测到肺炎衣原体。 PCR发现再狭窄患者中肺炎衣原体阳性病例多于IFT。在衣原体抗原的检测与血清学之间未发现关联。再狭窄的女性更经常吸烟(p = 0.012)。再狭窄的男性年龄明显更大(p = 0.015)。基于rELISA或MIFT的肺炎衣原体血清学与再狭窄没有任何相关性。结论:没有证据表明肺炎衣原体血清学阳性是发生再狭窄的危险因素。然而,在这些情况下,物种特异性的血清学检测,尤其是IgA抗体检测以及口咽标本中肺炎衣原体的PCR检测是否可能是可靠的诊断标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号